Summary In this report we describe the role of apoptosis in the process of tumour cell killing by bispecific monoclonal antibody (BsMAb)-redirected cytolytic T cells. The BsMAb used, BIS-1, has dual specificity for the CD3 complex on T cells and the pancarcinoma-associated 38 kDa transmembrane antigen EGP-2. BIS-1 allows activated T cells to specifically recognise and kill EGP-2-positive but not EGP-2-negative target cells. An assay was developed to quantify apoptosis in cells by separation of 3H-thymidine-labelled low-molecular, i.e. fragmented, from high-molecular, i.e. non-fragmented DNA. The presence of low molecular weight DNA was measured both within the target cells and in the cell-free supernatant. After exposure to BIS-1-redirected, -activated T cells, apoptosis was observed in EGP-2-positive target cells but not in EGP-2-negative target cells. Also no DNA fragmentation proved to be induced in the activated effector cells during assay. The degree of EGP-2-positive target DNA fragmentation depended on the concentration of BsMAb, the E/T ratio and the incubation time. Using a low E/T ratio (1/1), DNA fragmentation in and 5'Cr release from target cells showed similar characteristics and kinetics. At higher E/T ratio (20/1), the 5"Cr release from the target cells increased to a greater extent than the percentage fragmented target cell DNA. Inhibitors of DNA fragmentation added to the cytotoxicity assay inhibited not only DNA fragmentation, but also the release of chromium-51 from the target cells, suggesting that apoptosis and cell lysis are closely related in BsMAbmediated cell killing.
Activated cytotoxic T lymphocytes (CTLs) kill opposing target cells upon MHC class I restricted recognition. Direct bispecific monoclonal antibody (BsMAb)-mediated linking of some cell-surface molecules present on the CTLs with cellsurface molecules present on a target cell can direct the lethal hit of the CTLs towards a prechosen target cell population (Staerz et al., 1985; Garrido et al., 1990; Ferrini et al., 1992) . This BsMAb-redirected lysis is conducted irrespective of MHC class I expression by the target cells and T-cell receptor (TcR) specificity of the CTLs (Garrido et al., 1990) . Presumably the most potent T-cell surface structure that can be used to redirect the CTL activity is the CD3/TcR complex as present on all T lymphocytes (Garrido et al., 1990; Ferrini et al., 1992) .
CTLs may kill target cells by various mechanisms. The exact pathways or possible interplay between these mechanisms is as yet not fully understood (Berke, 1991; Krahenbuhl and Tschopp, 1991; Smyth et al., 1994; Smyth, 1992; Lowin et al., 1994) . CTLs contain granules in which a number of lytic molecules have been characterised. These include perforin or lymphotoxin, serine esterase or granzymes and proteoglycans. Proteoglycans are not lytic by themselves but are able to bind other lytic components and are thus thought to play a role in the deposition of the lytic constituents at the interface between the effector and target cell. Isolated perforin has been shown to be cytotoxic as it inserts itself in the cell membrane followed by polymerisation to form tubular structures that allow uncontrolled passage of small electrolytes and possibly larger macromolecules resulting in cell death by disturbed cellular homeostasis (Duke et al., 1989) . Both the insertion in the cell membrane and the polymerisation to transmembrane channels is dependent on the presence of Ca2 . The CTL-associated serine esterases or granzymes belong to a family of related serine proteases with a variety of substrate specificities (Peters et al., 1991; Das et al., 1994; Hayes et al., 1989; Wright et al., 1994 and Tschopp, 1991; Duke et al., 1989) . Granzymes co-localise with perforin in the lytic granules and have been shown to induce target cell DNA fragmentation, possibly by activation of intracellular endonucleases (Hayes et al., 1989; Smyth et al., 1994; Hudig et al., 1993) .
Although perforin is highly cytolytic by itself in the presence of free extracellular Ca2", target cell lysis is observed also under Ca2+-free conditions (Clark et al., 1988; Rouvier et al., 1993) . Furthermore, target cell lysis, although only to a minor extent, can be established using perforin-deficient CTLs (Kagl et al., 1994; Lowin et al., 1994) . These observations indicate the possibility that multiple lytic mechanisms can be displayed by CTLs to kill target cells. Indeed, it was recognised by Duke et al. (1983) that, in addition to target cell membrane damage, the induction of low molecular DNA, characteristic of apoptosis, was detectable during the process of cellular cytotoxicity. One particular problem in assessing target cell apoptosis is the fact that induction of DNA fragmentation may occur not only in the target cell, but also in the effector cell population (Lenardo, 1991; Ucker et al., 1992 Figure 1 DNA laddering w-ith DNA fragments of 200 basepair multimers. characteristic of apoptosis. is visualised after specific. BIS-1-directed cytotoxicity against the target cell lines GLC-1M13 (EGP-2-positive) whereas no such laddering could be established in GLC-1 (EGP-2-negative) cells. in the CTL population alone. or in the absence of BIS-1. are shown.
-_ (Figure 2 ), the amount of BIS-1 added to the assay (Figure 3 ) and the incubation time (Figure 4 ). Specific DNA fragmentation was found in the EGP-2-positive GLC-lM13 target cells ( Figure 2a ) but not the EGP-2-negative GLC-1 target cell (Figure 2b ), which is in agreement with the qualitative data shown in Figure 1 (Figure 3 ). It has been reported that DNA fragmentation precedes the release of chromium-51 from the target cells (Duke et al., 1983) . Using BIS-1-redirected CTLs, the time kinetics of DNA fragmentation proved to be essentially the same as those found with the 5"Cr-release assay (Figure 4 ). Using a low E/T ratio (E/T = 1), the to cytotoxicity performed at a loxw E T ratio and in parallel 'A-ith the elexated release of chromium-5 1. at a high E T ratio. substantial DNA release into the supernatant was found.
Confinemzent of DN.4 fragmenration to the relevant target population
DNA fragmentation can be detected in EGP-'-positive targzet cells upon specific BIS-1 BsMAb-mediated CTL cytotoxicitv (Figures 1 -4 [ H]thvmidine-labelled GLC-1 cells were added to a cytotoxicity assax in which specific BIS-1-directed cytotoxicitV against unlabelled GLC-1M13 u-as induced. The results are shown in Table I . No DNA fragmentation was found in the CTL effector cell population nor in the innocent GLC-1 bxstander cells. Of special interest is the fact that transfection of GLC-1 cells with EGP-2 encoding cDNA (GLC-I.EGP-2) renders this cell line sensitive to BIS-1-directed lx-sis bv CTLs as indicated bv both the induction of DNA fragmentation (Table I) and 'Cr-release (data not shox-n).
Inhibition of DV_.4 fragmnewtatiotn
To further examine whether BIS-1-mediated CTL-induced target cell DNA fragmentation on the one hand and tarzet cell l sis as measured bv l'Cr-release on the other. are independent processes or not. wve assessed the effect of addition of two known inhibitors of DNA fragmentation. As shown in Figure 5 . the addition of 50 mm zinc chloride or 90 mNi 3.4-dichloroisocoumarin (DCIC) during BIS-1-directed cellular cvtotoxicitv affected not onlv DNA fragmentation in. but also the release of chromium-S1 from target cells to the same extent. These concentrations of zinc chloride or DCIC did not affect intrinsic lymphocyte functions as assessed in a lymphocyte proliferation assay using anti-CD3 (MAb WT32) as mitogenic stimulants (not shown). Threefold higher concentrations of zinc chloride and DCIC. not onlv further reduced DNNA fragmentation but also proved to be toxic as a decreased lymphocyte proliferation capacit xx as noted. (Duke et al., 1989) . However in a more physiological setting it was shown that non-cytolytic rat basophilic leukaemia (RBL) cells could be turned into cytotoxic active effector cells only by co-transfection with both the perforin and granzyme A genes (Shiver et al., 1992 (Heusel et al.. 1994) . This is in line with observations reported by Shi et al. (1992) who showed that DNA fragmentation in target cells was dependent on prior treatment of these target cells with sublethal concentrations of perforn. Besides perforn, other mechanisms have been shown to be involved in the lethal hit delivery of CTLs. An important recently described effector mechanism seems to be mediated through the target cell-expressed Fas receptor, which has a widespread cellular distribution (Nagata and Golstein, 1995) . Interaction of the Fas receptor with the Fas ligand, which is up-regulated on activated CTLs, initiates an apoptotic program within the target cell that does not require extracellular Ca2 or de novo protein synthesis. Fas-mediated target cell killing has been implicated in the non-antigenspecific killing of CTLs (Rouvier et al., 1993; Lowin et al., 1994) and is characterised by the induction of an apoptotic suicide programme in the target cell. It seems unlikely however, that Fas-mediated killing played a significant role in the results described in this report since the non-specific (innocent bystander) killing was not observed in our experiments whereas GLC-1 as well as GLC-1M13 are both Fas positive (data not shown). Furthermore, no inter-effector cell killing was observed (Table I ) while these were found to be both Fas as well as Fas-ligand positive (data not shown).
An implication of the results shown in the present report is that clinical evaluation of the in vivo effectiveness of BsMAbmediated T-cell targeting might be possible. BsMAbmediated cellular immunotherapy has evolved over the last few years and clinical application is currently being investigated (Kroesen et al., 1994) . The need for evaluation of functional in vivo targeting has become apparent and protocols that have been described to specifically detect apoptotic cells either by flow cytometry or immunological staining biopsies (Wijsman et al., 1993; Gorczyca et al., 1993) might be helpful in this respect.
